Search clinical trials for: tenofovir/lamivudine

Total 1418 results

University of California, San Francisco
University of Miami

Recruiting

PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men (PrEP2-BAY)

Risk Reduction

United States
Centers for Disease Control and Prevention
Gilead Sciences; CDC Foundation

Completed

Sustainable Healthcenter Implementation PrEP Pilot Study (SHIPP)

HIV Preexposure Prophylaxis | HIV Chemoprophylaxis

United States
Jeil Pharmaceutical Co., Ltd.

Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901

Healthy Adult

Korea, Republic of
CONRAD
National Institute of Allergy and Infectious Diseases (NIAID); National Institute...

Completed

Rectal Safety and Acceptability Study of Tenofovir 1% Gel

Rectal Microbicides

United States
University of Colorado, Denver

Completed

The Cellular Pharmacology of F-TAF in Dried Blood Spots (TAF-DBS)

Healthy Volunteers

United States
Erasmus Medical Center
Gilead Sciences

Unknown

Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide (BACTAF)

Hiv | Renal Insufficiency,Chronic | Therapeutic Agent Toxicity

Netherlands
James Egan
National Institute of Mental Health (NIMH); Fenway Community Health

Completed

Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV

Human Immunodeficiency Virus

United States
Fuzhou General Hospital

Completed

TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction

Hepatitis B, Chronic

China
University of California, Los Angeles
Los Angeles County Department of Public Health; Los Angeles LGBT Center; The... and other collaborators

Completed

A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services (PATH-PrEP)

HIV Prevention

United States
Gilead Sciences

Completed

Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

HIV Infections

United States, United Kingdom, Panama
Philadelphia Fight

Completed

PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color

HIV

United States
Willem Daniel Francois Venter
Bill and Melinda Gates Foundation

Completed

Dose Optimisation of Stavudine for the Treatment of HIV Infection (D4T)

Human Immunodeficiency Virus | Acquired Immune Deficiency Syndrome

South Africa, India, Uganda
CONRAD
United States Agency for International Development (USAID); Follow-on African...

Completed

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

HIV Prevention

South Africa
Bristol-Myers Squibb

Completed

Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B

Hepatitis B, Chronic

Australia, France, India, Italy, United States, Canada, Poland, Russian Federation, Argentina, South Africa, Brazil, Turkey, Mexico
University of Modena and Reggio Emilia

Completed

A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)

HIV Infection

Italy
National Institute of Allergy and Infectious Diseases...

Completed

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

HIV Infections | Tuberculosis

Haiti
National Institute of Allergy and Infectious Diseases...
Initiative Senegalaise d'Acces aux Antiretroviraux (ISAARV)

Completed

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

HIV Infections

Senegal
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

Evaluation of the Bioequivalence of a Combined Formulated Tablet

Infection, Human Immunodeficiency Virus

United States
University of Zimbabwe
AIDS Care Research in Africa

Completed

Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa

HIV Infections | Cryptococcal Meningitis

Zimbabwe
National Institute of Allergy and Infectious Diseases...

Completed

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

HIV Infections

United States, Puerto Rico, Italy
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)

HIV-1 Infection

United States, Argentina, Canada, Chile, Colombia, France, Germany, Israel, Italy, Japan, South Africa, Spain, Taiwan
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Hepatitis B | Hepatitis B, Chronic | HBV

Hong Kong
Unity Health Toronto
Gilead Sciences; Ryerson University; Maple Leaf Research; AIDS Committee of Toronto and other collaborators

Completed

PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 (PREP-5)

HIV | Human Immunodeficiency Virus

Canada
Gilead Sciences

Completed

Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection

Hepatitis B Virus (HBV)

Turkey, United States, Romania, France, Poland, Bulgaria, Spain
Institute of Liver and Biliary Sciences, India

Completed

To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B

Spontaneous Reactivation of Hepatitis B

India
CONRAD
National Institute of Allergy and Infectious Diseases (NIAID); Microbicide...

Completed

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet (RMP02-MTN006)

HIV Infections | HIV Prevention

United States
Makerere University
Department of Foreign Affairs, Ireland

Completed

Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products

HIV Infections

Uganda
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission (OCTANE)

HIV Infections

South Africa, Botswana, Kenya, Malawi, Uganda, Zambia, Zimbabwe
ANRS, Emerging Infectious Diseases
Gilead Sciences; Janssen Pharmaceutica

Completed

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé) (2LADY)

HIV Infections | HIV

Burkina Faso, Cameroon, Senegal
Taipei Veterans General Hospital, Taiwan

Not yet recruiting

The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs

Inflammatory Arthritis | HBV
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Centre for the...

Recruiting

Simplifying Treatment and Monitoring for HIV (STREAM HIV)

HIV/AIDS | HIV-1-infection

South Africa
University of Nebraska

Completed

A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

HIV Prevention

United States
Antios Therapeutics, Inc

Terminated

A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection

Hepatitis D | Hepatitis B, Chronic

Moldova, Republic of, Ukraine
Enyo Pharma
Parexel; Novotech (Australia) Pty Limited; Synteract, Inc.; Eurofins

Terminated

Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)

Hepatitis B, Chronic

Australia, Hong Kong, Korea, Republic of, Poland
Philip Grant
Gilead Sciences

Completed

Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir (Near-Rwanda)

HIV

Rwanda
University of North Carolina, Chapel Hill
Ohio State University; Kinshasa School of Public Health

Completed

Arresting Vertical Transmission of Hepatitis B Virus (AVERT-HBV)

Hepatitis B | Vertical Transmission of Infectious Disease

Congo, The Democratic Republic of the
Asociación Civil Impacta Salud y Educación, Peru
Gilead Sciences

Unknown

Demonstration Project on the Feasibility to Implement PrEP in MSM and TG Women

HIV Prevention

Peru
St Stephens Aids Trust

Completed

A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine

HIV

United Kingdom
Oswaldo Cruz Foundation
University of Sao Paulo; Centro de Referência e Treinamento DST AIDS

Unknown

Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project. (PrEPBrasil)

HIV

Brazil
Makerere University
Infectious Diseases Institute, Uganda

Unknown

Nucleosides And Darunavir/Dolutegravir In Africa (NADIA)

Human Immunodeficiency Virus

Uganda
Babafemi Taiwo
ViiV Healthcare

Completed

Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure (ASPIRE)

HIV Infection

United States
University Ghent

Completed

Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers

Healthy

Belgium
Sun Yat-sen University

Unknown

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Recurrence | Hepatocellular Carcinoma | Hepatitis B Virus

China
ViiV Healthcare
Pfizer

Terminated

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)

HIV-1

United States, Netherlands, Spain, Puerto Rico, Canada, Australia, Germany, Sweden, Poland, Portugal, Switzerland, France, Denmark, Italy, Belgium, United Kingdom, Hungary, Austria, Finland
St Stephens Aids Trust

Completed

Atripla to Raltegravir Switch Study for CNS Toxicity (SSAT036)

HIV Infection

United Kingdom
Nanfang Hospital of Southern Medical University
Gilead Sciences; Tigermed Consulting Co., Ltd

Recruiting

Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)

Hepatitis B, Chronic | Mother to Child Transmission

China
University of California, Los Angeles
University of Cape Town

Active, not recruiting

Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women (PrEP-PP)

HIV-I Infection

South Africa
IlDong Pharmaceutical Co Ltd

Completed

Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues (HBV)

Chronic Hepatitis B

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Active, not recruiting

Phase 3 and Extensional Study of Besifovir

Chronic Hepatitis B

Korea, Republic of
ANRS, Emerging Infectious Diseases

Unknown

Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission (TA-PROHM)

Pregnancy | Hepatitis B Chronic Infection

Cambodia

Search clinical trials for: tenofovir/lamivudine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations